RHJA
Rice Hall James & Associates Portfolio holdings
AUM
$1.86B
1-Year Return
33.9%
This Quarter Return
+13.52%
1 Year Return
+33.9%
3 Year Return
+119.1%
5 Year Return
+206.57%
10 Year Return
+613.71%
AUM
$1.86B
AUM Growth
+$155M
(+9.1%)
Cap. Flow
-$9.15M
Cap. Flow
% of AUM
-0.49%
Top 10 Holdings %
Top 10 Hldgs %
25.53%
Holding
256
New
8
Increased
83
Reduced
147
Closed
9
Top Buys
| 1 |
Chart Industries
GTLS
|
+$15.9M |
| 2 |
WIX.com
WIX
|
+$14M |
| 3 |
Vail Resorts
MTN
|
+$7.04M |
| 4 |
Ziff Davis
ZD
|
+$6.98M |
| 5 |
WEX
WEX
|
+$6.62M |
Top Sells
| 1 |
VRNA
Verona Pharma
VRNA
|
+$20.3M |
| 2 |
Stride
LRN
|
+$19.1M |
| 3 |
RB Global
RBA
|
+$8.98M |
| 4 |
TKO Group
TKO
|
+$7.98M |
| 5 |
Federal Agricultural Mortgage
AGM
|
+$7.07M |
Sector Composition
| 1 | Healthcare | 31.2% |
| 2 | Technology | 28.31% |
| 3 | Industrials | 17.73% |
| 4 | Communication Services | 6.8% |
| 5 | Consumer Discretionary | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Chart Industries
GTLS
$8.98B
| $23.4M | 1.26% |
142,381
+96,406
| +210% | +$15.9M |
|
27
Radware
RDWR
$1.09B
| $22.2M | 1.2% |
754,135
-105,580
| -12% | -$3.11M |
|
28
Ituran Location and Control
ITRN
$685M
| $19.7M | 1.06% |
508,615
+18,698
| +4% | +$724K |
|
29
BioCryst Pharmaceuticals
BCRX
$1.72B
| $18.5M | 0.99% |
2,060,280
+32,712
| +2% | +$293K |
|
30
LeMaitre Vascular
LMAT
$2.2B
| $17.8M | 0.96% |
213,870
+3,248
| +2% | +$270K |
|
31
Kiniksa Pharmaceuticals
KNSA
$2.71B
| $17.7M | 0.95% |
638,233
+13,688
| +2% | +$379K |
|
32
Supernus Pharmaceuticals
SUPN
$2.58B
| $16.5M | 0.89% |
524,647
+8,758
| +2% | +$276K |
|
|
33
Vail Resorts
MTN
$5.64B
| $16.3M | 0.88% |
103,915
+44,776
| +76% | +$7.04M |
|
34
ReposiTrak
TRAK
$318M
| $16.2M | 0.87% |
826,799
-26,218
| -3% | -$515K |
|
35
Amicus Therapeutics
FOLD
$2.46B
| $15.8M | 0.85% |
2,760,314
+750,210
| +37% | +$4.3M |
|
36
Ingevity
NGVT
$2.21B
| $15.8M | 0.85% |
365,637
+1,421
| +0.4% | +$61.2K |
|
37
CRA International
CRAI
$1.27B
| $15.6M | 0.84% |
83,312
+1,821
| +2% | +$341K |
|
38
Acadia Pharmaceuticals
ACAD
$4.28B
| $14.4M | 0.78% |
669,806
-2,417
| -0.4% | -$52.1K |
|
39
Shutterstock
SSTK
$724M
| $14.2M | 0.77% |
750,665
+84,317
| +13% | +$1.6M |
|
40
Neurocrine Biosciences
NBIX
$14.3B
| $13.6M | 0.73% |
108,382
-1,291
| -1% | -$162K |
|
|
NEXN
41
Nexxen International
NEXN
$639M
| $13.5M | 0.73% |
1,293,799
+407,968
| +46% | +$4.25M |
|
42
Bank OZK
OZK
$5.92B
| $13.2M | 0.71% |
281,013
-2,507
| -0.9% | -$118K |
|
43
Maximus
MMS
$4.98B
| $12.9M | 0.7% |
184,084
-1,696
| -0.9% | -$119K |
|
44
Franklin Covey
FC
$243M
| $12.2M | 0.66% |
533,711
+9,916
| +2% | +$226K |
|
45
Alkermes
ALKS
$4.7B
| $12.1M | 0.65% |
421,885
-4,700
| -1% | -$134K |
|
46
Mirum Pharmaceuticals
MIRM
$3.89B
| $11.8M | 0.64% |
231,993
-2,703
| -1% | -$138K |
|
47
Harrow
HROW
$1.45B
| $11.3M | 0.61% |
370,627
+74,455
| +25% | +$2.27M |
|
48
Gentex
GNTX
$6.3B
| $9.82M | 0.53% |
446,548
-4,462
| -1% | -$98.1K |
|
49
Pool Corp
POOL
$12.5B
| $9.71M | 0.52% |
33,312
-399
| -1% | -$116K |
|
50
CEVA Inc
CEVA
$555M
| $9.69M | 0.52% |
440,875
+5,397
| +1% | +$119K |
|